Cutting-edge tests designed to help discover, analyze, and screen cancer cells at every step of the disease,
Research Genetics Cancer Center (RGCC) testing is offered to patients seeking early detection of cancer, monitoring of existing cancers, and a personalized profile of chemotherapeutic drugs and other natural substances that can be used for the best treatment outcome.
Watch this short video by Dr. Clayton Bell to learn more.
Testing Options
Onconomics Plus
Provides information about the efficacy of specific drugs, targeted therapies, and natural treatments on the cancer cells in an individual patient. The results give providers a comprehensive breakdown of the most suitable and successful treatments for cancer allowing them to create personalized and targeted cancer treatments.
Oncotrace
Provides information about the presence of Circulating Tumor Cells (CTCs), their concentration, and immunophenotype, which may help identify their origin and provide guidance about disease progression and future prognosis.
